D.N.A. Biomedical Solutions Ltd.

Complementary equity research reports on D.N.A. Biomedical Solutions Ltd.

Report Type

Publish Date


Initiation of Coverage 10 October 2017 pdf-icon_32x32.png
Initiation of Coverage - Hebrew Appendix 10 October 2017 pdf-icon_32x32.png
Q1 2018 Update 8 February 2018 pdf-icon_32x32.png
Q1 2018 Update - Hebrew Appendix 8 February 2018 pdf-icon_32x32.png
Q4 2017 Update 11 April 2018 pdf-icon_32x32.png
Q4 2017 Update - Hebrew Appendix 11 April 2018 pdf-icon_32x32.png

This site uses cookies. Cookies are used to track visitors to so we can better understand which portions of our site best serve you. This data will be used for the following purposes: Completion and support of the current activity and Web site and system administration. This data will be used only by Frost & Sullivan.